节点文献

99Tc-MDP与甲泼尼龙治疗Graves眼病的疗效比较

Clinical Efficacy Comparison on 99Tc-MDP and Methylprednisolone Treatment for Graves’ Ophthalmopathy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王慧卿王雪琴王桂英李银玉黄正丽张继敏尉杰忠

【Author】 WANG Huiqing;WANG Xueqin;WANG Guiying;LI Yinyu;HUANG Zhengli;ZHANG Jimin;YU Jiezhong;Department of Endocrinology,The Fifth People’s Hospital of Datong City;Brain Research Institute, Datong University;

【通讯作者】 尉杰忠;

【机构】 山西省大同市第五人民医院内分泌科山西大同大学脑科研究所

【摘要】 目的比较甲泼尼松龙和99Tc-MDP治疗Graves眼病的疗效。方法选择2012年1月—2016年10月在大同市第五人民医院住院治疗的甲状腺相关眼病(Graves ophthalmopathy,简称GO)患者共60例。随机分为甲泼尼龙治疗组即激素组(30例)和99Tc-MDP组(30例),激素组应用甲泼尼龙500 mg溶于0.9%氯化钠注射液100 mL,静脉滴注,1次/日,连续3日,每隔4天再继续静脉滴注3天,连续3次,99Tc-MDP组将99Tc-MDP 10 mg,A剂注入B剂瓶内,充分混匀,在室温下静置5 min后加入生理盐水250 mL中静脉缓慢滴入,2~3 h滴完,21 d为1疗程。治疗前后比较患者自觉症状、突眼度、复视等的改善情况。结果激素组总有效率在GO活动性、突眼度、复视及眼球运动障碍的改善方面高于99Tc-MDP组(χ2=4.800,4.593,4.509,3.976,P=0.028,0.032,0.034,0.046)。结论甲泼尼龙治疗GO优于99Tc-MDP。

【Abstract】 Objective To compare the clinical efficacy of 99Tc-MDP and methylprednisolone in treatment of Graves’ ophthalmopathy. Methods 60 patients with thyroid-associated ophthalmopathy were enrolled, who were hospitalized form January 2012 to October 2016 and randomly divided into the methylprednisolone therapy group(hormone group, 30 cases) and 99Tc-MDP group(30 cases). Hormone group was treated with methylprednisolone 500 mg dissolved in 100 mL of 0.9% sodium chloride injection, intravenous drip, once a day, 3 consecutive days, after 4 days to continue intravenous drip for 3 days, altogether for 3 consecutive times. In 99Tc-MDP group, 99Tc-MDP was injected with 10 mg of agent A into the bottle of agent B, added to normal saline 250 mL, after 5 minutes at room temperature, 99Tc-MDP was venous slowness Uniform infusion for 2~3 hours, 21 days for 1 courses. The improvement of conscious symptoms, exophthalmos and diplopia were compared before and after treatment. Results The total effective rate of the hormone group was significantly higher than that of the 99Tc-MDP group in the improvement of GO activity, exophthalmos, diplopia and ocular movement disorders(χ2=4.800, 4.593, 4.509, 3.976, P=0.028, 0.032, 0.034, 0.046). Conclusion The effect of methylprednisolone is better than 99Tc-MDP in treatment of Graves’ ophthalmopathy.

【基金】 山西省科技攻关项目(2106ZD0505)
  • 【文献出处】 中国卫生标准管理 ,China Health Standard Management , 编辑部邮箱 ,2019年02期
  • 【分类号】R581;R771.3
  • 【被引频次】2
  • 【下载频次】80
节点文献中: 

本文链接的文献网络图示:

本文的引文网络